DIAdvisor

DIAdvisor is a mobile and personal device being developed in Europe over the next four years by a consortium of 13 partners (including Novo Nordisk and several research universities) to help patients with type 1 and type 2 diabetes better predict glucose levels and the risk of hyperglycemia and hypoglycemia. DIAdvisor will take information about blood glucose, insulin delivery, exercise, and food intake, crunch these numbers with prediction algorithms, and advise users on an individualized treatment regimen to better control their diabetes. The tool will also allow for information to be sent directly to the patient’s physician to help him or her manage a patient’s diabetes care. Early studies in hospitals, according to the DIAdvisor website, have shown that the use of the DIAdvisor system results in a lower incidence of complications and reduced length of stay in the hospital. In a considerable show of support for the DIAdvisor tool, The European Commission has provided 7.1 million euros to the DIAdvisor project. As the number of patients requiring insulin continues to grow and the demand for informed physician advice increases, we believe a tool such as DIAdvisor will be immensely helpful for patients in self-managing their diabetes. You can get more information about DIAdvisor by visiting www.diadvisor.eu. Unfortunately, we have no indication of when DIAdvisor plans to reach the market, but we’ll make sure to keep you updated.